Human T-cell leukemia virus is a retrovirus that infects T-cells. One promising therapeutic agent is Cepharanthine, a natural alkaloid with antiviral properties.
Recently, cepharanthine, first discovered in China as the new drug for treating COVID-19, has recently been granted the national invention patent authorization, which has drawn great attention from inside and outside the industry.